Suzhou Fushilai Pharmaceutical Co., Ltd. (SHE:301258)
29.88
+0.81 (2.79%)
Apr 29, 2026, 4:00 PM EDT
SHE:301258 Market Cap
SHE:301258 has a market cap or net worth of 2.68 billion as of April 29, 2026. Its market cap has increased by 15.10% in one year.
Market Cap
2.68B
Enterprise Value
1.52B
Revenue
412.51M
Ranking
n/a
PE Ratio
71.57
Stock Price
29.88
Market Cap Chart
Since March 29, 2022, SHE:301258's market cap has decreased from 6.10B to 2.68B, a decrease of -56.06%. That is a compound annual growth rate of -18.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 29, 2026 | 2.68B | -8.06% |
| Dec 31, 2025 | 2.91B | 35.37% |
| Dec 31, 2024 | 2.15B | -27.24% |
| Dec 29, 2023 | 2.96B | -17.76% |
| Dec 30, 2022 | 3.60B | -41.00% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shanghai Universal Biotech | 2.65B |
| Shandong Sito Bio-technology | 2.67B |
| Cabio Biotech (Wuhan) | 2.58B |
| Jilin Jian Yisheng Pharmaceutical | 2.70B |
| Hubei Goto Biopharm | 2.72B |
| Shanghai Hile Bio-Technology | 2.53B |
| Zhejiang East Asia Pharmaceutical | 2.40B |
| Guangdong VTR Bio-Tech | 3.00B |